中华实验和临床病毒学杂志
中華實驗和臨床病毒學雜誌
중화실험화림상병독학잡지
CHINESE JOURNAL OF EXPERIMENTAL AND CLINICAL VIROLOGY
2009年
2期
118-120
,共3页
陈壮桂%李鸣%纪经智%陈虹%陈岩峰%陈奋华
陳壯桂%李鳴%紀經智%陳虹%陳巖峰%陳奮華
진장계%리명%기경지%진홍%진암봉%진강화
传染性单核细胞增多症%疱疹病毒4型,人%T淋巴细胞亚群%丙种球蛋白类%更昔洛韦
傳染性單覈細胞增多癥%皰疹病毒4型,人%T淋巴細胞亞群%丙種毬蛋白類%更昔洛韋
전염성단핵세포증다증%포진병독4형,인%T림파세포아군%병충구단백류%경석락위
Infectious mononucleosis%Herpesvirus 4,human%T lymphocyte subsets%Gmma-globulins%Ganciclovir
目的 探讨儿童传染性单核细胞增多症(IM)T细胞亚群的变化及免疫干预的有效性.方法 入选的48例患儿分为2组,治疗组患儿28例,用丙种球蛋白(IVIG)治疗,IVIG 400 mg/(kg·d),连用5 d;或IVIG 1g/(kg·d),连用2 d.对照组患儿20例,予更昔洛韦(GCV)5~10 mg/(kg·d)连用5 d.并予对症支持治疗.选择20例正常儿童作为健康对照.结果 健康儿童CD4(%)、CD8(%)及CD4/CD8比值分别为(34.12±3.53)%、(26.22±4.43)%及(1.41±0.3);IVIG组分别为(24.2±4.3)%、(36.4±6.8)%及(0.72±0.12);GCV组(23.7±5.1)%、(37.3±7.8)%及(0.67±0.13),健康对照组与两组IM患儿比较,差异有统计学意义(P<0.05);与治疗前比较,IVIG组患儿治疗后CD4(%)升高、CD8(%)下降及CD4/CD8比值升高(P<0.05);而GCV组患儿治疗前后上述指标无显著性变化(P>0.05);IVIG治疗组患儿临床症状及体征较GCV治疗组消失快(P<0.05),IVIG组患儿治疗有效率88.7%,GCV组患儿治疗有效率59.2%(χ2=3.97,P<0.05);IVIG组患儿平均住院日为(9.2±4.3)d,较GCV组(13.8±5.1)d明显缩短(t=-4.24,P<0.05);结论IM患儿除了病毒感染导致的直接影响外,存在明显的免疫功能紊乱;IVIG免疫干预治疗优于单纯抗病毒治疗.
目的 探討兒童傳染性單覈細胞增多癥(IM)T細胞亞群的變化及免疫榦預的有效性.方法 入選的48例患兒分為2組,治療組患兒28例,用丙種毬蛋白(IVIG)治療,IVIG 400 mg/(kg·d),連用5 d;或IVIG 1g/(kg·d),連用2 d.對照組患兒20例,予更昔洛韋(GCV)5~10 mg/(kg·d)連用5 d.併予對癥支持治療.選擇20例正常兒童作為健康對照.結果 健康兒童CD4(%)、CD8(%)及CD4/CD8比值分彆為(34.12±3.53)%、(26.22±4.43)%及(1.41±0.3);IVIG組分彆為(24.2±4.3)%、(36.4±6.8)%及(0.72±0.12);GCV組(23.7±5.1)%、(37.3±7.8)%及(0.67±0.13),健康對照組與兩組IM患兒比較,差異有統計學意義(P<0.05);與治療前比較,IVIG組患兒治療後CD4(%)升高、CD8(%)下降及CD4/CD8比值升高(P<0.05);而GCV組患兒治療前後上述指標無顯著性變化(P>0.05);IVIG治療組患兒臨床癥狀及體徵較GCV治療組消失快(P<0.05),IVIG組患兒治療有效率88.7%,GCV組患兒治療有效率59.2%(χ2=3.97,P<0.05);IVIG組患兒平均住院日為(9.2±4.3)d,較GCV組(13.8±5.1)d明顯縮短(t=-4.24,P<0.05);結論IM患兒除瞭病毒感染導緻的直接影響外,存在明顯的免疫功能紊亂;IVIG免疫榦預治療優于單純抗病毒治療.
목적 탐토인동전염성단핵세포증다증(IM)T세포아군적변화급면역간예적유효성.방법 입선적48례환인분위2조,치료조환인28례,용병충구단백(IVIG)치료,IVIG 400 mg/(kg·d),련용5 d;혹IVIG 1g/(kg·d),련용2 d.대조조환인20례,여경석락위(GCV)5~10 mg/(kg·d)련용5 d.병여대증지지치료.선택20례정상인동작위건강대조.결과 건강인동CD4(%)、CD8(%)급CD4/CD8비치분별위(34.12±3.53)%、(26.22±4.43)%급(1.41±0.3);IVIG조분별위(24.2±4.3)%、(36.4±6.8)%급(0.72±0.12);GCV조(23.7±5.1)%、(37.3±7.8)%급(0.67±0.13),건강대조조여량조IM환인비교,차이유통계학의의(P<0.05);여치료전비교,IVIG조환인치료후CD4(%)승고、CD8(%)하강급CD4/CD8비치승고(P<0.05);이GCV조환인치료전후상술지표무현저성변화(P>0.05);IVIG치료조환인림상증상급체정교GCV치료조소실쾌(P<0.05),IVIG조환인치료유효솔88.7%,GCV조환인치료유효솔59.2%(χ2=3.97,P<0.05);IVIG조환인평균주원일위(9.2±4.3)d,교GCV조(13.8±5.1)d명현축단(t=-4.24,P<0.05);결론IM환인제료병독감염도치적직접영향외,존재명현적면역공능문란;IVIG면역간예치료우우단순항병독치료.
objective To investigate changes of T lymphocytes subsets in children with infectious mononucleosis(IM) and the effects of different interventions.Methods Forty-eisht children with IM were Twenty healthy children from healthcare clinic serviced as control group.Results CD4(%),CD8(%)and the CD4,CD8 ratio in healthy control group were(34.12±3.53)%,(26.22±4.43)%and(1.41±0.3),in IVIG group were(24.2±4.3)%,(36.4±6.8)%and(0.72±0.12),and in GCV group were(23.7±5.1)%, (37.3±7.8)%and(0.67±0.13),respectively.CD4(%),CD8(%)and the ratio CD4/CD8 in the control grouD were significantly different from those in both groups with IM(P<0.05).Compared with pre-tratment levels.the 28 cases treated with IVIG had significant improvement,the CD4(%)increased,CD8(%)decreased and the ratio of CD4/CD8 increased after treatment(P<0.05).However,20 cases in GCV treatment group made less chunges(P>0.05).Meanwhile,the clinical symptoms and signs in the IVIG group were improved faster than that in the GCV group(P<0.05).The rate of remission in IVIG group was 88.7%vs.59.2%of GcV group(P<0.05);the hospital days in IVIG grouP were(9.2±4.3)days vs.(13.8±5.1)days in tlle GCV (P<0.05).Conclusion It is indicated that the subsets of T lymphocytes in periphend blood are obviously abnormal in children with IM caused by EBV infection in acute phase.WIG can regulate the immunological derangements of T lymphoeytes subsets,on which anti-viral therapy alone may have little impact.